IRON - NASDAQ

Disc Medicine, Inc.

IRON·NASDAQ

$70.35

-2.3%

HealthcareBiotechnology

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.69B

EPS-6.0100

P/E Ratio-11.71

Earnings Date08/06/2026

iron

Selling, General and Administrative Expenses

Last Annual Value

65.38M

3-Year CAGR

67%

5-Year CAGR

62%

10-Year CAGR

27%

Adjust for Inflation

Disc Medicine, Inc. Competitors Analysis of Selling, General and Administrative Expenses

IRON · NASDAQ

Company	Selling, General and Administrative Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
Disc Medicine, Inc. NASDAQ:IRON	65.38M	44.1%	62.5%	N/A
Tarsus Pharmaceuticals, Inc. NASDAQ:TARS	427.32M	57.8%	75.9%	N/A
Celcuity Inc. NASDAQ:CELC	27.20M	69.0%	59.9%	59.0%
CG Oncology, Inc. Common stock NASDAQ:CGON	73.53M	95.1%	73.8%	N/A
Apogee Therapeutics, Inc. NASDAQ:APGE	70.88M	42.3%	N/A	N/A
Adaptive Biotechnologies Corporation NASDAQ:ADPT	167.27M	-1.0%	-0.3%	N/A
Legend Biotech Corporation NASDAQ:LEGN	342.50M	19.5%	18.0%	N/A
Scholar Rock Holding Corporation NASDAQ:SRRK	176.21M	52.8%	34.3%	45.6%

Disc Medicine, Inc. Fair Value Envelope

IRON · NASDAQ

Our analysis suggests that IRON has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $70.35, this represents a potential HIDDEN relative to our calculated worth for Disc Medicine, Inc..

HIDDEN

Intrinsic Value

Current Price: $70.35

Related Guides

Blog Categories

Continue your IRON research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.